Sleep Disorders Trial, Recruiting NCT07120373 Sponsor: University of Nottingham Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT07120373
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

This trial has two main groups for patients, plus a group for healthcare professionals. The criteria for each are listed below.

Part 1 – People with a recent brain injury:

  • People aged 18 to 60 years old
  • People who have come to the Emergency Department within 24 hours of a head injury
  • People who have been medically diagnosed with a traumatic brain injury (TBI) of any level of severity
  • People who had their level of consciousness recorded by medical staff when they arrived at hospital
  • People who are able to give their own agreement to take part in the study
  • People who are able to wear a wrist activity tracker at home for two weeks, within 12 weeks of their injury

Part 2 – People with a brain injury from more than 12 months ago:

  • People aged 18 to 60 years old
  • People who have been medically diagnosed with a traumatic brain injury (TBI) of any level of severity
  • People who had their level of consciousness recorded in their medical notes
  • People who are able to give their own agreement to take part in the study
  • People whose brain injury happened more than 12 months ago
  • People who are able to wear a wrist activity tracker at home for two weeks

Part 2 – Healthcare professionals:

  • Registered healthcare professionals working at Nottingham University Hospitals Trust
  • Healthcare professionals who have experience delivering rehabilitation to brain injury patients who have been recruited to this study

Who may not be able to join:

For both patient groups (Parts 1 and 2):

  • People who are unable to understand what the study involves or cannot give their own agreement to take part
  • People who have another diagnosed neurological condition, such as stroke, brain tumour, epilepsy, motor neuron disease, Parkinson's disease, or spinal cord injury (this list may not be exhaustive — confirm with trial site)
  • People whose brain injury has not been formally defined or graded by a medical professional, or where the time since injury is unknown
  • People who have a diagnosed or self-reported sleep disorder, or where one is noted in their medical records
  • People who work night shifts as a regular part of their job
  • People who cannot be contacted by phone, letter, or email

For healthcare professionals (Part 2):

  • People who cannot be contacted by phone, letter, or email
  • People who are unable to understand what the study involves or cannot give their own agreement to take part

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Professor Holly Blake, University of Nottingham

Phone: +44115 823 1924

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Nottingham
Registry
ClinicalTrials.gov
Start date
21 October 2025
Est. completion
1 December 2026

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Functional outcome; Functional outcome

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov